Sexton Riley LLP represented Janssen Biotech, Inc. in a license agreement with LegoChem Biosciences, Inc. for LCB84, a clinical stage Trop2-directed ADC.
top of page
bottom of page
Sexton Riley LLP represented Janssen Biotech, Inc. in a license agreement with LegoChem Biosciences, Inc. for LCB84, a clinical stage Trop2-directed ADC.
Comments